Emilien Muggeo

Dr. Emilien Muggeo

Lausanne University Hospital (CHUV), Lausanne, Vaud, Switzerland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Rémy KinjRémy Kinj
Rémy Kinj
EMEmilien Muggeo
Emilien Muggeo
LSLuis Schiappacasse
Luis Schiappacasse
Jean BourhisJean Bourhis
Jean Bourhis
FHFernanda G. Herrera
Fernanda G. Herrera
Stereotactic body radiation therapy (SBRT) is a form of radiation therapy (RT) in which a small number of high doses of radiation are delivered to a target volume using highly sophisticated equipment. Stereotactic body radiation therapy is crucial in two cancer stages: early primary cancer and oligometastatic disease, with the goal of inducing complete cancer remission in both. This treatment method is commonly used to treat a variety of disease types. Over the years, a growing body of clinical evidence on the use of SBRT for the treatment of primary and metastatic tumors has accumulated, with efficacy and safety demonstrated in randomized clinical trials. This article will review the technical and clinical aspects of SBRT according to disease type and clinical indication.